Stokes Capital Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
LMFP
ATO
QP
Stokes Capital Advisors's MRK Position: Q2 2026 in Review
Stokes Capital Advisors increased its Merck (MRK) stake by 31% in Q2 2026, buying an estimated $149K and bringing the position to 5,373 shares worth $690K. The position accounts for 0.15% of the portfolio, ranked #70.
Stokes Capital Advisors first reported a position in MRK in Q2 2020 and has held it in 22 quarters since. The position peaked at $4.86M in Q3 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Stokes Capital Advisors held 5,373 shares of Merck worth $690K as of Q2 2026.
- Stokes Capital Advisors bought 1,275 Merck shares in Q2 2026, an estimated $149K.
- Merck made up 0.15% of Stokes Capital Advisors's portfolio in Q2 2026, its #70 holding.
- Stokes Capital Advisors first reported a position in Merck in Q2 2020 and has held it in 22 quarters since.
- Stokes Capital Advisors's Merck position peaked at $4.86M in Q3 2024.
- 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Stokes Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.